公司資料

NGM Biopharmaceuticals 股價、新聞與催化劑

股票代碼:
NGM
交易所:
NASDAQ
產業:
Biopharma
所在地:
United States

股價為何變動

目前無法取得 NGM 的收盤價變動背景。

公司概覽

業務概覽

NGM Biopharmaceuticals is a biotech company focused on metabolic, liver, and oncology programs. Its business has been shaped by a broad platform approach and ongoing portfolio decisions.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, NGM sits in specialty biotechnology.

商業模式特徵

The company depends on pipeline prioritization, clinical data, and the ability to create value from a broad discovery engine.

生技產業定位

NGM is a platform biotech name whose valuation depends on the quality of its selected programs.

未來催化劑

  • NGM is now largely a legacy and strategic-closeout story, so the catalysts are any asset monetization, wind-down, or portfolio-simplification update. The market is mainly waiting for clarity on the remaining corporate value.

近期新聞

新聞標題由機器翻譯,詳情為英文原文。

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商業成熟度、治療領域或催化劑模式相近的同業公司。